feed,title,long_url,short_url
TheStreet,Biogen Analysts Upgrade Stock Amid Alzheimer's Drug Controversy,https://www.thestreet.com/investing/biogen-biib-stock-analysts-upgrade-alzheimers-drug-controversy,https://j.mp/2TTVRTP
